HPV 16 E7/ETAd DNA vaccine (Johns Hopkins University)

N/A

Report date: 2025/03/20 16:10:07

Base Information

Drug NameHPV 16 E7/ETAd DNA vaccine (Johns Hopkins University)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionProtein E7 modulators

TargetsProtein E7

Therapy Area/IndicationsUterine Cervical Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesJohns Hopkins University

China Registration ClassN/A

Develop Information

Active CompaniesJohns Hopkins Technology Ventures Johns Hopkins University

Inactive CompaniesN/A

Active IndicationsUterine Cervical Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A